According to the current analysis of Reports and Data, the global Nucleic Acid Labeling market valued at USD 1,878.8 Million in 2020 and is expected to reach USD 3,571.9 Million by the year 2028, at a CAGR of 8.4%. A wide variety of molecular and cellular biology procedures are dependent on a labeled or tagged nucleic acid. These behavior and functioning can be specifically studied via the attached label. Nucleic acids can be easily labelled with several tags that allows their detection and purification. These tags can be used to recover or identify other interacting molecules.  The integrity of the nucleic acid is preserved in this non-destructive reaction, which makes it useful for applications where it is necessary to use the intact sample.

Owing to the growing demand for nucleic acid labeling, the manufacturers are adapting strategic initiatives such as innovative launch systems to increase their product portfolio. For example, with the launch of PHOTOPROBE labeling systems, the total length of the original nucleic acid sample, instead of copies, is directly marked. Additionally, Nucleic Acid Labeling can also be used for applications involving protein interactions, such as gel change or drip analysis, it is generally advantageous to generate labeled probes at the end to avoid steric interference of the interaction.

Market Overview:

The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Some key highlights of the report:

• Nucleic Acid labeling market is growing at a CAGR of 1% in Asia Pacific followed by Europe and North America, with 8.3 % and 8.2% CAGR, respectively. Increasing Healthcare Expenditure across the globe is the key factor to accelerate the market growth during forecast period across all regions
• As of 2019, Reagents Kits is the dominating Nucleic Acid Labeling which holds 53.2% of the global market. European regional market is the prominent revenue generating source for this product segment, followed by North America, Asia-Pacific and, other regions
• Services Product Type segment is expected to be the fastest growing market segment during forecast period 2019-2027 with a CAGR of 9.1%. However, Fierce competitive structure of Nucleic Acid Labeling market is a major challenge for the market growth of this market segment
• Random Primer Technique type segment was valued at USD 255 Million in the year 2019 and is expected reach USD 608 Million by 2027, growing at a highest CAGR of 9.7%.
• Asia Pacific is anticipated to account for the 20.1% of the global Nucleic Acid Labeling market. Developing nations such China, and India are likely to witness high growth
• Lack of skilled professionals is a major challenge for the market growth across the globe during the forecast period

 Key Players covered in this report are

Promega Corporation, Thermo Fisher Scientific, Inc., General Electric Company, New England Biolabs, PerkinElmer, Inc., F. Hoffmann La-Roche AG, Vector Laboratories, Merck KGaA, Enzo Biochem, and Agilent Technologies.

Product Type (Revenue, USD Million; 2018–2028)

• Reagents Kits
• Services

Technique Type (Revenue, USD Million; 2018–2028)

• PCR
• Nick Translation
• Random Primer
• In Vitro Transcription
• Reverse Transcription
• End Labeling

Label Type (Revenue, USD Million; 2018–2028)

• Biotin-based
• Fluorescent
• Radioactive

End Use (Revenue, USD Million; 2018–2028)

• Hospital
• Clinic
• Others

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
•  

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2252  

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.